Skip to main content
main-content

Oncology

Editor's pick

Endocrine therapy impacts cardiovascular risk in women with breast cancer

Heart and white pills

Long-term use of adjuvant endocrine therapy by women with a history of nonmetastatic breast cancer can significantly alter their risk for some types of cardiovascular disease, a meta-analysis shows.

ASCO 2018: Abi Race trial in prostate cancer

Lead author Daniel George discusses his team's findings of a greater and longer lasting treatment effect with abiraterone acetate and prednisone in Black than White men with metastatic castration-resistance prostate cancer (3:59). 

ASCO 2018: CARMENA trial in renal cell carcinoma

Arnaud Méjean presents the CARMENA trial findings, suggesting that cytoreductive nephrectomy may no longer be the standard of care for metastatic renal cell carcinoma in the era of sunitinib (4:21).

ASCO 2018: TAILORx trial in breast cancer

Joseph Sparano gives an overview of his team's findings regarding a 21-gene prognostic test that could help tailor treatment for women with early breast cancer (3:24).

ASCO 2018: IMPACT trial across multiple cancers

Apostolia Tsimberidou discusses the findings of the IMPACT study, looking at the survival benefits of matching targeted treatments to the genetic alterations of tumors across multiple cancer types (7:56).

15-10-2018 | Oncology | Main feed | News

approvalsWatch

HPV vaccination age expanded in the USA

Click here for details

11-10-2018 | Oncology | Main feed | News

Screen-detected colon cancer patients experience fewer complications

Patients whose colon cancers are detected by routine screening have fewer postoperative complications than individuals whose cancers are diagnosed outside of a national programme, study findings indicate.

Source:

JAMA Surg 2018; doi:10.1001/jamasurg.2018.3567

11-10-2018 | Breast cancer | News | Article

News in brief

Postmenopausal weight loss linked to reduced breast cancer risk

Postmenopausal women who lose weight have a lower risk for breast cancer than those who maintain a stable weight, report researchers.

10-10-2018 | Oncology | News | Article

Short-term hospitalization, mortality risk varies by palliative chemotherapy regimen

Two independent studies of older patients receiving initial chemotherapy for metastatic breast cancer or non-small-cell lung cancer have found that the risk for hospitalization or death may be predicted by the cytotoxic regimen used.

Source:

Cancer 2018; doi:10.1002/cncr.31760
JAMA Network Open 2018; 1: e183023

PET Best For Predicting Follicular Lymphoma Response To Immunochemotherapy

Response to treatment on the end-of-induction positron emission tomography scan is a better predictor of follicular lymphoma survival than computed tomography Read the full story on ESMO's oncologyPRO educational website (for registered ESMO members).

Twitter Icon Follow medwireNews

Click here
image credits